Prevalence of depression and anxiety was observed in patients with myasthenia gravis (MG) as an effect of the unpredictable progression of the disease. Increase knowledge about the psychological and psychopathological disorders in patients with MG. We focused on the analysis of the psychological assessment realized at a point before randomization of patients included in the MGEX Study. Qualitative and quantitative methods: self-report questionnaires to evaluate: anxiety (STAI A-B), depression (Beck depression inventory, BDI-13), psychiatric disorders (MINI, French Version 5.0.0), self-esteem (Self- esteem inventory scale, SEI), quality of life with a MG-specific scale (MGQOL-15-F).

Read More...

Leave a comment.

Your email address will not be published. Required fields are marked*

Andoird App
Loading...